Our results indicate that higher levels of CSF YKL-40 may promote AD progression, and constitute a reasonable pathway to connect the effects of hypertension and neuroinflammation with astrocyte reactivity in contributing to AD pathogenesis. The gene discussed is CHI3L1; the disease is Alzheimer disease.